{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:14:19Z","timestamp":1788491659128,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2021-00013"],"award-info":[{"award-number":["PICT-2021-00013"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007351","name":"Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["20020220400016BA"],"award-info":[{"award-number":["20020220400016BA"]}],"id":[{"id":"10.13039\/501100007351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-026-02713-6","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:42:49Z","timestamp":1788489769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-hyperuricemia therapy alleviates diet-induced gut inflammation via AhR-IL-22-signalling"],"prefix":"10.1007","volume":"104","author":[{"given":"Soledad","family":"Bouquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola L\u00f3pez","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Ottobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9558-5974","authenticated-orcid":false,"given":"Maite","family":"Duhalde-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"2713_CR1","doi-asserted-by":"publisher","first-page":"1287468","DOI":"10.3389\/fmicb.2023.1287468","volume":"14","author":"Q Lv","year":"2023","unstructured":"Lv Q, Wang B, Zhang X et al (2023) A dynamics association study of gut barrier and microbiota in hyperuricemia. Front Microbiol 14:1287468. https:\/\/doi.org\/10.3389\/fmicb.2023.1287468","journal-title":"Front Microbiol"},{"issue":"40","key":"2713_CR2","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.3748\/wjg.v30.i40.4404","volume":"30","author":"AK Singh","year":"2024","unstructured":"Singh AK, Pramanik K, Banerjee R et al (2024) Elucidating the role of gut microbiota dysbiosis in hyperuricemia and gout: Insights and therapeutic strategies. World J Gastroenterol 30(40):4404\u20134410. https:\/\/doi.org\/10.3748\/wjg.v30.i40.4404","journal-title":"World J Gastroenterol"},{"issue":"8","key":"2713_CR3","doi-asserted-by":"publisher","first-page":"101060","DOI":"10.1016\/j.jhepr.2024.101060","volume":"6","author":"L Liu","year":"2024","unstructured":"Liu L, Wang X, Zhang Y et al (2024) Xanthine oxidase promotes hepatic lipid accumulation through high fat absorption by the small intestine. JHEP Rep 6(8):101060. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101060","journal-title":"JHEP Rep"},{"issue":"8","key":"2713_CR4","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1016\/j.bbadis.2018.05.003","volume":"1864","author":"MG Battelli","year":"2018","unstructured":"Battelli MG, Bortolotti M, Polito L et al (2018) The role of xanthine oxidoreductase and uric acid in metabolic syndrome. Biochim Biophys Acta Mol Basis Dis 1864(8):2557\u20132565. https:\/\/doi.org\/10.1016\/j.bbadis.2018.05.003","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2713_CR5","doi-asserted-by":"publisher","first-page":"1291853","DOI":"10.3389\/fnut.2023.1291853","volume":"10","author":"X Jia","year":"2023","unstructured":"Jia X, Wang Y, Gao X et al (2023) Exploring a novel therapeutic strategy: the interplay between gut microbiota and high-fat diet in the pathogenesis of metabolic disorders. Front Nutr 10:1291853. https:\/\/doi.org\/10.3389\/fnut.2023.1291853","journal-title":"Front Nutr"},{"key":"2713_CR6","doi-asserted-by":"publisher","unstructured":"Rinninella E, Cintoni M, Raoul P et al (2023) The role of diet in shaping human gut microbiota. Best Pract Res Clin Gastroenterol 62\u201363. https:\/\/doi.org\/10.1016\/j.bpg.2023.101828","DOI":"10.1016\/j.bpg.2023.101828"},{"key":"2713_CR7","doi-asserted-by":"publisher","unstructured":"Mamun MAA, Al-Harbi NO, Anwar F et al (2025) Impact of a High-Fat Diet on the Gut Microbiome: A Comprehensive Study of Microbial and Metabolite Shifts During Obesity. Cells 14(6). https:\/\/doi.org\/10.3390\/cells14060463","DOI":"10.3390\/cells14060463"},{"issue":"16","key":"2713_CR8","doi-asserted-by":"publisher","first-page":"e36024","DOI":"10.1016\/j.heliyon.2024.e36024","volume":"10","author":"X Yang","year":"2024","unstructured":"Yang X, Cui Y, Li X et al (2024) Hyperuricemia drives intestinal barrier dysfunction by regulating gut microbiota. Heliyon 10(16):e36024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36024","journal-title":"Heliyon"},{"key":"2713_CR9","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3389\/fmicb.2018.02233","volume":"9","author":"Y Yu","year":"2018","unstructured":"Yu Y, Liu Q, Li H et al (2018) Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats. Front Microbiol 9:2233. https:\/\/doi.org\/10.3389\/fmicb.2018.02233","journal-title":"Front Microbiol"},{"key":"2713_CR10","doi-asserted-by":"publisher","first-page":"e8664","DOI":"10.7717\/peerj.8664","volume":"8","author":"X Liu","year":"2020","unstructured":"Liu X, Jiao X, Ren Y et al (2020) The altered gut microbiota of high-purine-induced hyperuricemia rats and its correlation with hyperuricemia. PeerJ 8:e8664. https:\/\/doi.org\/10.7717\/peerj.8664","journal-title":"PeerJ"},{"key":"2713_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13099-017-0208-7","volume":"9","author":"Z Feng","year":"2017","unstructured":"Feng Z, Luo W, Li Y et al (2017) A human stool-derived Bilophila wadsworthia strain caused systemic inflammation in specific-pathogen-free mice. Gut Pathog 9:59. https:\/\/doi.org\/10.1186\/s13099-017-0208-7","journal-title":"Gut Pathog"},{"issue":"2","key":"2713_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, Iannitti RG, De Luca A et al (2013) Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39(2):372\u2013385. https:\/\/doi.org\/10.1016\/j.immuni.2013.08.003","journal-title":"Immunity"},{"key":"2713_CR13","doi-asserted-by":"publisher","unstructured":"Su X, Gao Y, Yang R (2022) Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis. Cells 11(15). https:\/\/doi.org\/10.3390\/cells11152296","DOI":"10.3390\/cells11152296"},{"issue":"6","key":"2713_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H (2018) Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe 23(6):716\u2013724. https:\/\/doi.org\/10.1016\/j.chom.2018.05.003","journal-title":"Cell Host Microbe"},{"issue":"6","key":"2713_CR15","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2017.08.028","volume":"153","author":"S Nikolaus","year":"2017","unstructured":"Nikolaus S, Bauditz J, Schreiber S et al (2017) Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases. Gastroenterology 153(6):1504\u20131516e2. https:\/\/doi.org\/10.1053\/j.gastro.2017.08.028","journal-title":"Gastroenterology"},{"key":"2713_CR16","doi-asserted-by":"publisher","first-page":"117864692110705","DOI":"10.1177\/11786469211070533","volume":"15","author":"J Chen","year":"2022","unstructured":"Chen J, Vitetta L, Volenzuela A et al (2022) Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis. Int J Tryptophan Res 15:11786469211070533. https:\/\/doi.org\/10.1177\/11786469211070533","journal-title":"Int J Tryptophan Res"},{"key":"2713_CR17","doi-asserted-by":"publisher","unstructured":"Galligan JJ (2018) Beneficial actions of microbiota-derived tryptophan metabolites. Neurogastroenterol Motil 30(2). https:\/\/doi.org\/10.1111\/nmo.13283","DOI":"10.1111\/nmo.13283"},{"issue":"1","key":"2713_CR18","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR (2018) Microbial tryptophan catabolites in health and disease. Nat Commun 9(1):3294. https:\/\/doi.org\/10.1038\/s41467-018-05470-4","journal-title":"Nat Commun"},{"key":"2713_CR19","doi-asserted-by":"publisher","unstructured":"Tong S, Zhang X, Tan X et al (2022) The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment. Front Cell Infect Microbiol 12: p. 1051682. https:\/\/doi.org\/10.3389\/fcimb.2022.1051682","DOI":"10.3389\/fcimb.2022.1051682"},{"issue":"1","key":"2713_CR20","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1038\/s41598-022-08249-2","volume":"12","author":"J An","year":"2022","unstructured":"An J, Liu Y, Wang Y et al (2022) The source of the fat significantly affects the results of high-fat diet intervention. Sci Rep 12(1):4315. https:\/\/doi.org\/10.1038\/s41598-022-08249-2","journal-title":"Sci Rep"},{"key":"2713_CR21","doi-asserted-by":"publisher","unstructured":"Romero-Garmendia I, Besga A, Castro-Bujanda E et al (2018) Subcellular Fractionation from Fresh and Frozen Gastrointestinal Specimens. J Vis Exp 137. https:\/\/doi.org\/10.3791\/57740","DOI":"10.3791\/57740"},{"issue":"23","key":"2713_CR22","doi-asserted-by":"publisher","first-page":"8093","DOI":"10.1128\/AEM.02787-15","volume":"81","author":"C Darkoh","year":"2015","unstructured":"Darkoh C, Chappell C, Gonzales-Luna A et al (2015) A rapid and specific method for the detection of indole in complex biological samples. Appl Environ Microbiol 81(23):8093\u20138097. https:\/\/doi.org\/10.1128\/AEM.02787-15","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"2713_CR23","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1074\/jbc.M807328200","volume":"284","author":"J Jeong","year":"2009","unstructured":"Jeong J, Kim YI, Jung SH HS, et al (2009) Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells. J Biol Chem 284(6):3700\u20133708. https:\/\/doi.org\/10.1074\/jbc.M807328200","journal-title":"J Biol Chem"},{"issue":"6","key":"2713_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nm.4102","volume":"22","author":"B Lamas","year":"2016","unstructured":"Lamas B, Natividad JM, Sokol H et al (2016) CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 22(6):598\u2013605. https:\/\/doi.org\/10.1038\/nm.4102","journal-title":"Nat Med"},{"key":"2713_CR25","doi-asserted-by":"publisher","unstructured":"Jang HM, Lee KE, Kim DH (2019) The Preventive and Curative Effects of Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 on Immobilization Stress-Induced Anxiety\/Depression and Colitis in Mice. Nutrients 11(4). https:\/\/doi.org\/10.3390\/nu11040819","DOI":"10.3390\/nu11040819"},{"key":"2713_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mib.2017.07.003","volume":"39","author":"Y Litvak","year":"2017","unstructured":"Litvak Y, Byndloss MX, B\u00e4umler AJ (2017) Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction. Curr Opin Microbiol 39:1\u20136. https:\/\/doi.org\/10.1016\/j.mib.2017.07.003","journal-title":"Curr Opin Microbiol"},{"key":"2713_CR27","doi-asserted-by":"publisher","unstructured":"Ahmed K, Choi HN, Cho SR, Yim JE (2024) Association of Firmicutes\/Bacteroidetes Ratio with Body Mass Index in Korean Type 2 Diabetes Mellitus Patients. Metabolites 14(10):518. https:\/\/doi.org\/10.3390\/metabo14100518","DOI":"10.3390\/metabo14100518"},{"key":"2713_CR28","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.3389\/fmicb.2018.02494","volume":"9","author":"EO Mendez-Salazar","year":"2018","unstructured":"Mendez-Salazar EO, Ortiz-Lopez MG, Granados-Silvestre MA et al (2018) Altered Gut Microbiota and Compositional Changes in Firmicutes and Proteobacteria in Mexican Undernourished and Obese Children. Front Microbiol 9:2494. https:\/\/doi.org\/10.3389\/fmicb.2018.02494","journal-title":"Front Microbiol"},{"issue":"1","key":"2713_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/advances\/nmz061","volume":"11","author":"MW Rohr","year":"2020","unstructured":"Rohr MW, Narasimhulu CA, Rudeski-Rohr TA et al (2020) )Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review. Adv Nutr 11(1):77\u201391. https:\/\/doi.org\/10.1093\/advances\/nmz061","journal-title":"Adv Nutr"},{"issue":"1","key":"2713_CR30","doi-asserted-by":"publisher","first-page":"105905","DOI":"10.1016\/j.isci.2022.105905","volume":"26","author":"GG Kang","year":"2022","unstructured":"Kang GG, Trevaskis NL, Murphy AJ et al (2022) Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH. iScience 26(1):105905. https:\/\/doi.org\/10.1016\/j.isci.2022.105905","journal-title":"iScience"},{"issue":"6957","key":"2713_CR31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01991","volume":"425","author":"YE Shi","year":"2003","unstructured":"Shi YE, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425(6957):516\u2013521. https:\/\/doi.org\/10.1038\/nature01991","journal-title":"Nature"},{"key":"2713_CR32","doi-asserted-by":"publisher","first-page":"1668173","DOI":"10.3389\/fimmu.2025.1668173","volume":"16","author":"H Kang","year":"2025","unstructured":"Kang H, Kim M, Lee J et al (2025) The AhR\/IL-22 axis in chronic gut inflammation: unraveling mechanisms and therapeutic prospects. Front Immunol 16:1668173. https:\/\/doi.org\/10.3389\/fimmu.2025.1668173","journal-title":"Front Immunol"},{"key":"2713_CR33","doi-asserted-by":"publisher","unstructured":"Kasahara K, Kerby RL, Zhang Q et al (2023) Gut bacterial metabolism contributes to host global purine homeostasis. Cell Host Microbe, 31(6):1038\u20131053e10. https:\/\/doi.org\/10.1016\/j.chom.2023.05.011","DOI":"10.1016\/j.chom.2023.05.011"},{"issue":"3","key":"2713_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3349\/ymj.2022.63.3.241","volume":"63","author":"HW Kim","year":"2022","unstructured":"Kim HW, Yu HT, Kim SY et al (2022) Distinct Gut Microbiota in Patients with Asymptomatic Hyperuricemia: A Potential Protector against Gout Development. Yonsei Med J 63(3):241\u2013251. https:\/\/doi.org\/10.3349\/ymj.2022.63.3.241","journal-title":"Yonsei Med J"},{"key":"2713_CR35","doi-asserted-by":"publisher","first-page":"935723","DOI":"10.3389\/fcimb.2022.935723","volume":"12","author":"Z Wang","year":"2022","unstructured":"Wang Z, Zhang Y, Wang S et al (2022) Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout. Front Cell Infect Microbiol 12:935723. https:\/\/doi.org\/10.3389\/fcimb.2022.935723","journal-title":"Front Cell Infect Microbiol"},{"key":"2713_CR36","doi-asserted-by":"publisher","first-page":"524236","DOI":"10.3389\/fphys.2020.524236","volume":"11","author":"Q Lu","year":"2020","unstructured":"Lu Q, Chen C, Lao X et al (2020) Association of Hyperuricemia With Immune Disorders and Intestinal Barrier Dysfunction. Front Physiol 11:524236. https:\/\/doi.org\/10.3389\/fphys.2020.524236","journal-title":"Front Physiol"},{"issue":"5","key":"2713_CR37","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3389\/fmicb.2025.1599107","volume":"40","author":"WR Xie","year":"2022","unstructured":"Xie WR, Siah K, Wong S et al (2022) Effects of Washed Microbiota Transplantation on Serum Uric Acid Levels, Symptoms, and Intestinal Barrier Function in Patients with Acute and Recurrent Gout: A Pilot Study. Dig Dis 40(5):684\u2013690. https:\/\/doi.org\/10.3389\/fmicb.2025.1599107","journal-title":"Dig Dis"},{"issue":"10","key":"2713_CR38","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.bbadis.2013.05.002","volume":"1832","author":"AC Dankers","year":"2013","unstructured":"Dankers AC, Mutsaers SE, Ryffel B et al (2013) Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP). Biochim Biophys Acta 1832(10):1715\u20131722. https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.002","journal-title":"Biochim Biophys Acta"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02713-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02713-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02713-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:42:50Z","timestamp":1788489770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-026-02713-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2713"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02713-6","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experimentation was conducted in accordance with international ethical standards (Helsinki Declaration and its amendments, Amsterdam Protocol of welfare and animal protection, and National Institutes of Health, USA, guidelines: Guide for the Care and Use of Laboratory Animals). Experiments were approved by the Institutional Committees for the Care and Use of Laboratory Animals of the Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Argentina (CICUAL; Protocol number #82307\/2019 and #530238\/2024).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"105"}}